|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED-B
Nominal 
36.050 +1.550 (+4.493%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 2.33
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | -270.00 RMB (cts) | |
| Net Profit | -844.46 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | -930.00 | -297.00 | 0 | -- | -914.00 | -1,006.00 |
| 2025 | -232.00 | -74.00 | 0 | -- | 40.00 | -278.00 |
| 2026 | 182.50 | 57.10 | 0 | -- | 236.00 | 129.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | -1,006.00 | -310.40 | -- | BOCOM | Buy | 44.00 | 28/08/2024 | |
| 2024 | -930.00 | -297.00 | -- | BANK OF AMERICA | Buy | 25.20 | 28/08/2024 | |
| 2024 | -914.00 | -292.10 | -- | CITIGROUP | Neutral | 25.00 | 28/08/2024 | |
| 2025 | -278.00 | -85.70 | -- | BOCOM | -- | -- | 28/08/2024 | |
| 2025 | 40.00 | 12.60 | -- | BANK OF AMERICA | -- | -- | 28/08/2024 | |
| 2025 | -232.00 | -74.00 | -- | CITIGROUP | -- | -- | 28/08/2024 | |
| 2026 | 236.00 | 72.90 | -- | BOCOM | -- | -- | 28/08/2024 | |
| 2026 | 129.00 | 41.30 | -- | BANK OF AMERICA | -- | -- | 28/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 19/11/2024 14:02 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -632,413,000 |
| %Change | 49.291% |
| EPS / (LPS) | RMB -1.970 |
| NBV Per Share (¥) | RMB 13.567 |